Katherine Chastain

Natural compounds targeting major cell signaling pathways: a novel paradigm for osteosarcoma therapy

Review · Journal of Hematology & Oncology · 2017 · 142 citations

Daratumumab plus bortezomib, lenalidomide and dexamethasone for transplant-ineligible or transplant-deferred newly diagnosed multiple myeloma: the randomized phase 3 CEPHEUS trial

Nature Medicine · 2025 · 139 citations